Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page
- Check3 days agoChange DetectedFooter branding and links were updated to reflect the sponsor and related trial site, and the page revision tag was updated from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check10 days agoChange DetectedPublications section was added, including a citation for a Nat Commun article and notes that publications are automatically filled from PubMed, signaling new study outputs. Several footer/branding items ('Moffitt Cancer Center Clinical Trials website', 'H. Lee Moffitt Cancer Center and Research Institute', 'Helpful Links Provided by') were removed.SummaryDifference0.4%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4. This reflects a minor update to the page's metadata.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s release/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a site or system revision rather than a change to the study details.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page footer.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page shows new study record date entries for 2026-04-02, 2026-03-31, and 2026-03. Older dates 2026-02-10, 2026-01-29, and 2026-01 have been removed.SummaryDifference0.2%

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.